Summary. COVID‐19 is an infectious disease caused by severe acute respiratory coronavirus 2 (SARS‐CoV‐2). Vesicular skin rashes have been reported as associated
1 August 2020 in Journal of the American Academy of Dermatology
We have read with great interest the article: Cutaneous manifestations in COVID‐19: a first perspective by Recalcati S.1 This article is the first report of the cutaneous manifestations in Coronavirus Disease 2019 (COVID‐19) patients during the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic in Lombardy, Italy.
30 March 2021 in Journal of the European Academy of Dermatology and Venereology
The coronavirus disease 2019 (COVID‐19) has been associated to a wide clinical spectrum of skin manifestations, including chilblain‐like, urticarial, vesicular, maculopapular, livedoid and vasculitic lesions, among others1,2. However, the exact pathophysiology for the appearance of skin lesions is still unknown. Several hypotheses have been suggested, including viral hypersensitivity reactions, overexpression of type I interferons, COVID‐19 induced coagulopathy, thrombotic microangiopathy and direct viral damage3–6.